Age-related changes of serum N-acetyl-aspartate in healthy controls

Age and Ageing

Volumn 40, Issue 3, 2011, Pages 391-395

  Ruggieri, Maddalena ^a   Tortorella, Carla ^a   Ceci, Edmondo ^a   Paolicelli, Damiano ^a   Solfrizzi, Vincenzo ^a   di Bitonto, Giovanna ^a   Pica, Carmela ^a   Mastrapasqua, Mariangela ^a   Livrea, Paolo ^a   Trojano, Maria ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AMINO ACID BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; ISOTOPE DILUTION ASSAY; LETTER; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; SEX DIFFERENCE; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AGING; ASPARTIC ACID; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, LIQUID; COHORT STUDIES; FEMALE; HUMANS; INFANT; MALE; MASS SPECTROMETRY; MIDDLE AGED; SEX FACTORS; YOUNG ADULT;

EID: 79955447365     PISSN: 00020729     EISSN: 14682834     Source Type: Journal    
DOI: 10.1093/ageing/afr021     Document Type: Letter

References (25)

1. Rudkin TM, Arnold DL. Proton magnetic resonance spectroscopy for the diagnosis and management of cerebral disorders. Arch Neurol 1999; 56: 919-26.
2. Goldstein FB. The enzymatic synthesis of N-acetyl-L-aspartic acid by subcellular preparations of rat brain. J Biol Chem 1969; 244: 4257-60.
3. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J. Neurochem 1992; 59: 55-61.
4. Bates TE, Strangward M, Keelan J et al Inhibition of N-acetylaspartate production: implications for 1H MRS studies in vivo. Neuroreport 1996; 7: 1397-400.
5. Fujita T, Katsukawa H, Yodoya E et al Transport characteristics of N-acetyl-L-aspartate in rat astrocytes: involvement of sodium-coupled high-affinity carboxylate transporter NaC3/NaDC3-mediated transport system. J Neurochem 2005; 93: 706-14.
6. Madhavarao CN, Moffett JR, Moore RA et al Immunohistochemical localization of aspartoacylase in the rat central nervous system. J Comp Neurol 2004; 472: 318-29.
7. Kelley RI, Stamas JN. Quantification of N-acetyl-L-aspartic acid in urine by isotope dilution gas chromatography-mass spectrometry. J Inherit Metab Dis 1992; 15: 97-104.
8. Lu D, Pavlakis SG, Frank Y et al Proton MR spectroscopy of the basal ganglia in healthy children and children with AIDS. Radiology 1996; 199: 423-28.
9. Davie CA, Hawkins CP, Barker GJ et al Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994; 117: 49-58.
10. Meyerhoff DJ, MacKay S, Constans JM et al Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994; 36: 40-7.
11. Grodd W, Krageloh-Mann I, Petersen D, Trefz FK, Harzer K. In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 1990; 336: 437-8.
12. MacKay S, Meyerhoff DJ, Constans JM et al Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol 1996; 53: 167-74.
13. Sibbitt WL Jr, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. A.J.N.R. Am J Neuroradiol 1997; 18: 1271-77.
14. Schuff N, Amend DL, Knowlton R et al Age-related metabolite changes and volume loss in the hippocampus by magnetic resonance spectroscopy and imaging. Neurobiol Aging 1999; 20: 279-85.
15. Teunissen CE, Iacobaeu E, Khademi M et al Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis. Neurology 2009; 72: 1322-29.
16. Stevens H, Jakobs C, de Jager AEJ, Cunningham RT, Korf J. Neuron-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke. Eur J Clin Invest 1999; 29: 6-11.
17. Jasperse B, Jakobs C, Eikelenboom MJ et al N-acetylaspartic acid in cerebrospinal fluid of multiple sclerosis patients determined by gas-chromatography-mass spectrometry. J Neurol 2007; 254: 631-37.
18. Ross B, Lin A, Harris K, Bhattacharya P, Schweinsburg B. Clinical experience with 13C MRS in vivo. NMR Biomed 2003; 16: 358-69.
19. Gruber S, Pinker K, Riederer F et al Metabolic changes in the normal aging brain: consistent findings from short and long echo time proton spectroscopy. Eur J Radiol 2008; 68: 320-27.
20. Hetherington H, Kuzniecky R, Pan J et al Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T. Ann Neurol 1995; 38: 396-404.
21. Pan JW, Hetherington HP, Vaughan JT et al Evaluation of multiple sclerosis by 1H spectroscopic imaging at 4.1 T. Magn Reson Med 1996; 36: 72-77.
22. Kantarci K, Jack CR Jr, Xu YC et al Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a1H MRS study. Neurology 2000; 55: 210-17.
23. Abe K, Takanashi M, Watanabe Y et al Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology 2001; 43: 537-41.
24. Clifford RJ, Weigand SD, Shiung MM et al Atrophy rates accelerate in amnestic mild cognitive impairment. Neurology 2008; 70: 1740-52.
25. Mueller EA, Moore MM, Kerr DCR et al Brain volume preserved in healthy elderly through the eleventh decade. Neurology 1998; 51: 1555-62.